HR3243Referred to Committee

Therapeutic Fraud Prevention Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-05-07
Introduced
170
Cosponsors
HR
ⓘ
Type

Sponsor

Ted Lieu
Ted Lieu
Democrat · CA · Representative
Votes with party: 97.8% (638 recorded votes)

Full profile: /officials/L000582

Source: Congress.gov · FEC

Cosponsors (170)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-05-07

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would establish new federal rules to prevent fraudulent claims about health treatments and therapies, likely giving the government stronger authority to investigate and punish companies that make false or misleading promises about what their products can cure or treat. The measure would affect manufacturers, sellers, and marketers of health products and therapies, as well as consumers who rely on accurate information when making healthcare decisions. It aims to protect people from wasting money on treatments that don't actually work as advertised.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Commerce
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.